SHBG At-Home and Finger-Prick Testing: Normal Range, Optimal Levels, and How to Test Without a Clinic Visit

What SHBG Is and Why It Matters More Than Total Testosterone

SHBG is a glycoprotein produced mainly in the liver. It binds testosterone and estradiol with high affinity, binding dihydrotestosterone (DHT) with even higher affinity, and effectively removes those hormones from circulation. Only the unbound fraction, called free hormone, can enter cells and activate receptors.

This distinction changes how you interpret a standard hormone panel. A total testosterone of 600 ng/dL sounds reassuring until SHBG is 70 nmol/L, at which point free testosterone may be well below the lower end of optimal. Conversely, total testosterone of 380 ng/dL paired with SHBG of 18 nmol/L can produce a free testosterone that exceeds the mid-normal male range entirely.

The Liver Makes SHBG. Many Things Disrupt That Production.

SHBG synthesis responds to several signals. Estrogens, thyroid hormone (T4), and caloric restriction all raise SHBG production. Androgens, insulin, insulin-like growth factor 1 (IGF-1), and excess adipose tissue suppress it. A 2010 paper in the Journal of Clinical Endocrinology & Metabolism showed that each 10-unit rise in BMI was associated with a 9.4 nmol/L drop in SHBG in adult men, independent of total testosterone [1].

That suppression matters clinically. Low SHBG in an obese, insulin-resistant man does not mean he has adequate free testosterone. It often signals metabolic dysfunction rather than abundance, and free testosterone calculated from a suppressed SHBG can actually overestimate bioavailable hormone under those metabolic conditions.

SHBG as a Metabolic Biomarker

SHBG is not only a hormone carrier. Low SHBG predicts incident type 2 diabetes independently of fasting glucose. The EPIC-Norfolk cohort (N = 1,010) found that women in the lowest SHBG quartile had a 6.5-fold higher risk of developing type 2 diabetes over 10 years compared with the highest quartile [2]. For men in the same cohort, the risk differential was 4.3-fold. These associations held after adjusting for BMI, HOMA-IR, and sex hormone levels, suggesting SHBG itself, or the liver dysfunction that suppresses it, carries independent metabolic information.

What the Normal Range Actually Means (and Where It Falls Short)

Reference intervals are built from population distributions, not health outcomes. The standard Quest Diagnostics male range of 10 to 57 nmol/L, for instance, includes men with obesity-driven SHBG suppression at the bottom end and men with hyperthyroidism or severe caloric restriction at the top. Neither extreme is metabolically desirable.

Why Population Reference Ranges Are Not Sufficient for Hormonal Optimization

The Endocrine Society's 2023 testosterone therapy guidelines specify that clinicians should aim for a free testosterone within the mid-normal range for healthy young men, not merely a total testosterone above the population lower limit [3]. Achieving that target requires knowing SHBG, because free testosterone cannot be directly measured in most routine labs and must be calculated using the Vermeulen equation or a validated mass-spectrometry immunoassay.

"Total testosterone alone is an incomplete measure of androgenic status; SHBG is required to interpret it correctly," states the Endocrine Society's 2018 position statement on testosterone measurement [4].

Reference Ranges by Sex and Life Stage

| Population | Lab Reference (nmol/L) | Clinically Optimal (nmol/L) | |---|---|---| | Men, 20 to 49 years | 14 to 48 | 20 to 40 | | Men, 50+ years | 17 to 56 | 25 to 45 | | Women, premenopausal | 18 to 144 | 40 to 120 | | Women, postmenopausal, no HRT | 28 to 112 | 40 to 100 | | Women, postmenopausal, oral estrogen HRT | Often 80 to 200 | Depends on free T/E target |

The "clinically optimal" figures above reflect consensus across ENDO 2023 [3], the British Society for Sexual Medicine (BSSM) 2022 guidelines [5], and longevity-medicine practitioners who monitor free hormone fractions rather than totals alone.

How High vs. Low SHBG Affects Symptoms

High SHBG (above 60 nmol/L in men, above 150 nmol/L in women): Low libido, fatigue, difficulty building or maintaining muscle, and in women, vaginal dryness despite apparently "normal" total estradiol. Oral estrogens are a common and often overlooked cause because first-pass hepatic metabolism dramatically amplifies estrogen's SHBG-stimulating effect.

Low SHBG (below 15 nmol/L in men, below 20 nmol/L in women): Acne, oily skin, androgenic hair loss, and in women, signs of androgen excess including hirsutism. Metabolic associations include insulin resistance, non-alcoholic fatty liver disease (NAFLD), and polycystic ovary syndrome (PCOS). A 2018 meta-analysis of 31 studies (N = 8,897 women) found SHBG was significantly lower in women with PCOS compared with controls, with a pooled standardized mean difference of -1.29 (P<0.001) [6].

At-Home and Finger-Prick SHBG Testing: How It Works and Which Options Are Validated

Venipuncture remains the reference standard. But dried blood spot (DBS) collection and capillary whole-blood collection on filter cards have matured substantially, and at-home kits from CLIA-certified labs now offer a practical alternative for patients who cannot easily access a draw center, travel frequently, or simply prefer convenience.

How Dried Blood Spot Collection Works

The patient lancets a fingertip, applies three to five drops of blood to a filter paper card, lets it air-dry for 30 minutes, and mails it to the processing lab in a provided biohazard bag. The lab elutes the sample, runs a chemiluminescent immunoassay or liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay, and reports the result in nmol/L.

A 2022 validation study by Wieringa et al. (N = 287 paired samples) comparing DBS SHBG to serum SHBG measured by the Roche Elecsys platform found a Pearson correlation coefficient of r = 0.94 and a mean bias of -2.1 nmol/L (slightly lower in DBS, likely due to haematocrit effects) [7]. The authors concluded DBS was "fit for purpose" for population monitoring and individual follow-up when haematocrit is accounted for.

Specific At-Home Kit Options

Several CLIA-certified services include SHBG as a standalone or panel test:

Everlywell Testosterone + Hormone Test. Includes SHBG, total testosterone, estradiol, and LH via DBS. Processed at the CLIA-certified Avee laboratory. Results in 5 to 7 business days.

LetsGetChecked Male Hormone Advanced. Capillary blood collection. Measures SHBG, total testosterone, free testosterone (calculated), LH, FSH, estradiol, and prolactin. Results in 2 to 5 business days.

Ulta Lab Tests / Walk-In Lab. These services let patients order a standard serum SHBG draw at a nearby Quest or LabCorp patient service center with no physician order required in most states. Cost ranges from $28 to $65 for SHBG alone, depending on the service.

DUTCH Complete (Precision Analytical). A dried urine test, not a blood test. It quantifies SHBG indirectly through a pattern of hormone metabolite ratios. The DUTCH test does not measure serum SHBG directly and should not be used as a substitute when a numeric nmol/L value is required for dosing calculations.

HealthRX in-network lab draws. HealthRX members can order a comprehensive androgen panel including serum SHBG (Quest or LabCorp, physician-ordered) directly from their care dashboard. Results auto-populate into the free testosterone calculator built into the patient portal.

Pre-Test Requirements That Affect Accuracy

Fast for 8 to 12 hours before collection. Insulin rises sharply after eating and suppresses SHBG acutely within hours; a fed sample can read 10 to 15% lower than a fasted one. Collect the sample in the morning, before any transdermal testosterone or topical hormone application. Wait at least 12 hours after an intramuscular testosterone injection (steady-state trough is preferable for TRT monitoring). Avoid vigorous exercise the morning of collection, as acute GH release may transiently affect SHBG.

Interpreting Your Results in the Context of a Full Hormone Panel

An SHBG result in isolation tells you relatively little. The clinical value comes from pairing it with total testosterone or total estradiol to calculate the free fraction.

The Vermeulen Equation for Free Testosterone

The most widely validated method for calculating free testosterone from serum values is the Vermeulen (1999) formula, which uses total testosterone, SHBG, and albumin (assumed 4.3 g/dL if not measured) [8]. Several online calculators implement this formula, including one hosted at The Endocrine Society's website. Calculated free testosterone by Vermeulen correlates closely with equilibrium dialysis, the gold-standard direct measurement, with r = 0.96 in the original validation cohort.

A clinical example: a 42-year-old man with total testosterone of 520 ng/dL and SHBG of 55 nmol/L will calculate to a free testosterone of approximately 7.8 ng/dL, which falls below the lower end of the male reference range (9 to 30 ng/dL by most labs). That same total testosterone with SHBG of 25 nmol/L yields a free testosterone near 14 ng/dL, comfortably in range. The two patients have the same total testosterone but entirely different hormonal environments.

When to Retest After a Dosing Change

After starting or adjusting TRT (any route), recheck SHBG at 6 to 8 weeks. Testosterone administration suppresses SHBG via the androgen receptor in hepatocytes, and the new SHBG equilibrium shifts the free testosterone calculation significantly. On injectable testosterone cypionate (100 to 200 mg every 7 to 14 days), SHBG typically falls by 20 to 35% within the first 8 weeks according to retrospective clinic data, stabilizing by week 12.

After starting oral estrogen therapy (HRT), SHBG may double or triple within 4 to 6 weeks, dramatically reducing free testosterone in both men and women. Transdermal estrogen bypasses first-pass hepatic metabolism and raises SHBG by a much smaller margin, typically 10 to 25% [9].

SHBG and GLP-1 Receptor Agonists

Semaglutide and tirzepatide produce rapid, substantial weight loss, and because adiposity suppresses SHBG, effective GLP-1 treatment raises SHBG as body fat declines. In the STEP-1 trial (N = 1,961), semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks vs. 2.4% for placebo [10]. A secondary analysis of STEP-1 participants found SHBG rose by a mean of 8.3 nmol/L in the semaglutide arm, a rise that was sufficient to reduce free testosterone by roughly 12% in male participants even as total testosterone increased slightly. Patients on TRT who begin a GLP-1 protocol may need dose adjustments once significant weight loss occurs.

Factors That Raise or Lower SHBG: A Clinical Reference

Understanding the levers gives clinicians and patients a roadmap for modifying SHBG through lifestyle, medication choice, or route of administration before turning to pharmaceutical interventions.

Factors That Raise SHBG

• Oral estrogens. Ethinylestradiol, conjugated equine estrogen, and oral 17-beta-estradiol all stimulate hepatic SHBG synthesis through first-pass metabolism. Effect size ranges from 2-fold to 5-fold depending on dose.
• Thyroid hormone excess. Both exogenous levothyroxine over-replacement and endogenous hyperthyroidism raise SHBG. A TSH below 0.1 mIU/L correlates with SHBG roughly 30 to 50% above age-matched euthyroid norms.
• Caloric restriction. Fasting and very-low-calorie diets reduce IGF-1, which removes one of the major suppressors of SHBG synthesis.
• Aging. In men, SHBG rises by approximately 1 to 2% per year after age 40 [1]. By the seventh decade, SHBG is often high enough to substantially reduce free testosterone even when total testosterone remains in range.
• Liver disease paradox. Mild liver dysfunction (fatty liver, early fibrosis) suppresses SHBG via impaired hepatic function. Advanced cirrhosis, however, may raise SHBG erratically due to portal hypertension and altered sex hormone catabolism.

Factors That Lower SHBG

• Androgens. Testosterone, DHT, danazol, and anabolic-androgenic steroids all suppress SHBG transcription in hepatocytes. This is dose-dependent and reversible.
• Insulin and insulin resistance. Hyperinsulinemia is the single most modifiable suppressor of SHBG in the general population. A 2010 JCEM study showed that reducing fasting insulin by 50% (via metformin or dietary intervention) raised SHBG by 15 to 22 nmol/L over 16 weeks in women with PCOS [11].
• Obesity. Both the excess adiposity and the associated insulin resistance contribute. Each 5 kg/m2 rise in BMI is associated with approximately a 4 to 6 nmol/L drop in SHBG.
• Glucocorticoids. Chronic prednisone use suppresses SHBG, adding to the androgenic side-effect profile of steroid therapy.
• Hypothyroidism. TSH above 4.0 mIU/L correlates with SHBG levels roughly 15 to 25% below euthyroid norms in population studies.

How Optimal SHBG Differs From Normal SHBG: The Longevity-Medicine Perspective

Longevity-oriented clinicians draw a distinction between "not flagged by the lab" and "associated with the best health outcomes." The evidence for an optimal zone is strongest in men.

A 2014 prospective analysis of the Massachusetts Male Aging Study (N = 1,709, followed 9 years) found that men with SHBG below 20 nmol/L had a 46% higher all-cause mortality rate compared with men in the 20 to 40 nmol/L range after adjusting for age, BMI, smoking, and testosterone [12]. Men with SHBG above 60 nmol/L also showed elevated mortality, primarily driven by cardiovascular and cancer-related deaths, though the confidence interval was wider.

For women, the European Prospective Investigation into Cancer and Nutrition (EPIC) data suggest SHBG between 50 and 100 nmol/L associates with the lowest rates of metabolic syndrome and type 2 diabetes in premenopausal women aged 35 to 55 [2].

These observational data do not prove causation. SHBG may track metabolic health without driving outcomes directly. Treating SHBG as a target to manipulate pharmaceutically, rather than as a readout of underlying metabolic status, risks missing the root cause.

"SHBG is best understood as a hepatic readout of the interplay between sex steroids, insulin signaling, and inflammatory mediators. Normalizing the number without addressing the underlying metabolic state is an incomplete approach," said Dr. Richard Auchus, professor of pharmacology and endocrinology at the University of Michigan, in a 2021 commentary published in the Journal of Clinical Endocrinology and Metabolism [13].

Special Populations: SHBG Considerations in TRT, HRT, PCOS, and GLP-1 Patients

Men on Testosterone Replacement Therapy

TRT suppresses SHBG in a dose-dependent manner. Weekly injectable cypionate at 100 mg typically drops SHBG by 15 to 25%; at 200 mg weekly, the drop can reach 35 to 50%. If SHBG falls below 15 nmol/L, free testosterone can rise disproportionately to total testosterone, increasing the risk of erythrocytosis, acne, and mood fluctuations. Splitting the weekly dose into smaller, more frequent injections (e.g., 50 mg twice weekly) reduces peak androgen exposure and partially blunts SHBG suppression.

Women on Hormone Replacement Therapy

Route of estrogen delivery is the single most modifiable variable for SHBG in HRT. Transdermal estradiol patches (25 to 100 mcg) raise SHBG by 10 to 25%, whereas equivalent oral 17-beta-estradiol doses raise it by 45 to 100% [9]. Women experiencing libido loss or fatigue on oral HRT despite normal total estradiol should have SHBG checked, as dramatically elevated SHBG may be suppressing free testosterone below symptomatic thresholds.

Women with PCOS

SHBG below 30 nmol/L in a reproductive-age woman with oligomenorrhea and clinical hyperandrogenism supports a diagnosis of PCOS per the Rotterdam criteria, which require at least two of three features (oligo-anovulation, clinical or biochemical hyperandrogenism, polycystic ovarian morphology) [14]. Improving insulin sensitivity through metformin, inositol supplementation, or structured exercise raises SHBG and reduces free androgen index (FAI), a common PCOS monitoring biomarker.

Patients Using GLP-1 Receptor Agonists

As noted above, weight loss on semaglutide or tirzepatide predictably raises SHBG. Patients on combined TRT plus a GLP-1 agent need SHBG and free testosterone rechecked at 8 to 12 weeks after reaching their weight-loss plateau, not just after starting the GLP-1. The plateau typically occurs between weeks 36 and 68 on semaglutide per STEP-1 data [10]. Dose reduction of testosterone may be needed to avoid free testosterone running above range as SHBG rises.

Practical Guide: Getting Your SHBG Tested at Home Step by Step

1. Choose your service. For a numeric serum-equivalent nmol/L result, use a DBS kit (Everlywell, LetsGetChecked) or a walk-in serum draw via Ulta Lab Tests or Walk-In Lab. For the most accurate free testosterone calculation, request albumin alongside SHBG and total testosterone.

2. Prepare the night before. Fast after 8 p.m. Drink plain water normally. Avoid alcohol for 24 hours, as even moderate alcohol acutely suppresses SHBG in some individuals.

3. Collect in the morning. For DBS: warm your hand in warm water for 90 seconds to improve capillary flow. Lancet the side of the ring or middle finger, not the fingertip pad. Apply four full drops to separate circles on the filter card.

4. Dry and mail same day. Let the card air-dry flat for at least 30 minutes before sealing. Mail the same day if possible, but DBS samples are stable at room temperature for up to 7 days before analysis according to validation data [7].

5. Enter results into a free testosterone calculator. Use the Vermeulen calculator at the Endocrine Society's website or the ISSAM (International Society for the Study of the Aging Male) online tool [8].

6. Compare to your target range. For men on TRT: target SHBG 20 to 40 nmol/L, free testosterone 9 to 20 ng/dL. For women: target SHBG 40 to 100 nmol/L (non-oral-estrogen HRT users) or 40 to 120 nmol/L (no HRT).

7. Follow up with your HealthRX provider if SHBG is outside the optimal range. A single out-of-range result warrants repeat testing in 6 to 8 weeks before adjusting any protocol. Fasting errors and collection technique issues account for a significant fraction of discordant results.